**T2 Biosystems Announces Amendments and Voting Results from Annual Meeting**Lexington, Massachusetts – T2 Biosystems, Inc. (NASDAQ: TTOO) recently disclosed significant updates from its recent Annual Meeting with stockholders held on December 30, 20

* This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read T2 Biosystems’s 8K filing here. T2 Biosystems Company Profile (Get Free Report) T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United […]

Leave a Reply

Your email address will not be published.

Previous post TLGY Acquisition Appoints Kwong Cho Ho as Chief Financial Officer
Next post Bluerock Homes Trust Grants LTIP Units to Board Members in lieu of Equity Compensation